July 7 | Speakers
In response to shockwaves sent through the healthcare system, telehealth has made a name for itself. But even before COVID-19, the platform was increasing access and allowing fuss-free visits in specialties ranging from neurology to genomics and plenty in between. Here panelists will speak to the versatility of this solution and give their predictions for additional applications as a result of its newfound popularity.
Moderator: Will Morris, MD,
Executive Medical Director, Cleveland Clinic
Dr. William Morris is the Executive Medical Director of Cleveland Clinic Innovations. Dr. Morris has been a staff member of Hospital Medicine at Cleveland Clinic since 2006. In his former role as Associate Chief Information Officer he had oversight of design, development, and deployment of all clinical IT systems and health IT innovations. Dr. Morris also continues to practice medicine, and in 2017 was elected to Board of Governors on which he currently serves.
Dr. Morris earned his medical degree from Case Western Reserve University School of Medicine and completed training in Internal Medicine at Beth Israel Deaconess Medical Center, Harvard Medical School. He also received his MBA in 2017 from Case Western Reserve University Weatherhead School of Management.
Jennifer Schneider, MD,
Lisa Alderson, CEO & Co-Founder, Genome Medical
Lisa Alderson is the CEO and Co-Founder of Genome Medical, Inc., a leading genomics technology and services company that is transforming the delivery of medicine by enabling access to genomic-based medicine for everyday care. Through its nationwide network of genetic specialists and efficient Genome Care DeliveryTM technology platform, Genome Medical provides health expertise throughout the genomics journey.
Prior, Ms. Alderson served as the Chief Commercial Officer and Chief Strategy Officer of Invitae (NYSE: NVTA), a rapidly growing genetic information company. She was also the former CEO and president of CrossLoop Inc., a marketplace for technical services (acquired by Nasdaq: AVG). Prior to that, she was part of the start-up team at Genomic Health Inc. (Nasdaq: GHDX), president of Cinema Circle Inc., (acquired by Nasdaq: GAIA) and the former manager of strategic planning at The Walt Disney Co. Lisa also serves on the board of the Kidney Cancer Association. She has a track record of creating, funding and managing high-growth ventures. Lisa has an MBA with distinction from Harvard Business School and a B.A. from Colorado State University, where she graduated Summa Cum Laude.
Ann Mond Johnson, CEO, American Telemedicine Association (ATA)
Ann Mond Johnson joined the American Telemedicine Association (ATA) as CEO in 2018. Her experience includes building, launching and leading client driven companies that have been innovators in healthcare technology and data to support consumers using healthcare.
Prior to joining the ATA, Ann served as CEO of Zest Health, a technology-enabled service; as Board Chair and Advisor to ConnectedHealth, a leading provider of private insurance exchanges; and as co-founder and CEO of Subimo, a pioneer in healthcare cost and quality decision support tools for consumers. Ann began her career in healthcare data and information as Senior Vice President at Sachs Group (now part of IBM Watson/Truven Health). She also worked at a multi-hospital system in Minneapolis which is now part of Allina.
Ann’s ability to inspire and lead diverse teams has helped build both profitable organizations and innovation in the industry. Widely acknowledged as a thought leader, she presents at a range of professional meetings and conferences. She also maintains an active professional network and affiliations, including membership in the Healthcare Executive Leadership Network and Women Business Leaders of US Healthcare. Ann served on the Healthcare Advisory Council for UMB Bank and as an advisor to several start-ups. She was inducted in the Chicago Entrepreneurship Hall of Fame in 2016.
Ann’s involvement also extends to non-profit service organizations, including serving on the board of Round Earth Media, a non-profit organization focused on journalism (now part of the International Women’s Media Foundation). She is a member of the Ambassadors Council for N Street Village in Washington, DC and currently serves on the board of Pathfinder International, a non-profit organization committed to country-led solutions to achieve universal sexual and reproductive health and rights.
Peter Rasmussen, MD, Chief Clinical Officer for CCAW JV, LLC
Peter A. Rasmussen, MD, is Staff in the Cerebrovascular Center, and Medical Director of Distance Health Cleveland Clinic, and an Associate Professor at Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Dr. Rasmussen received his BS in biochemistry from the University of Wisconsin, Madison, in 1987. He earned his medical degree from the University of Wisconsin Medical School in 1991.
In addition, Dr. Rasmussen is a past-President of the Society of Neurointerventional Surgery where he played a leading role on the national stage in continuing society initiatives to resource, train and support veteran and new practitioners in an area of medicine that is transforming treatment approaches to neurovascular conditions.
President, Livongo Health
Dr. Jennifer Schneider is the President of Livongo. In this role, she is responsible for product, data science, engineering, marketing, and clinical operations. Dr. Schneider previously served as the company’s Chief Medical Officer where she led the company’s strategic clinical product vision, data science, clinical trials, and the organization’s certified diabetes educators and coaches. She is the author of Decoding Health Signals: Silicon Valley’s Consumer-First Approach to a New Era of Health, which offers a guide to the depth of the chronic conditions problem facing the industry today and explores how companies are using big data analytics and artificial intelligence to reinvent care delivery for people with chronic conditions.
Prior to Livongo, Dr. Schneider held several key leadership roles at Castlight Health, most recently as Chief Medical Officer. She also has held leadership roles in the provider setting as a health outcomes researcher and Chief Resident at Stanford University, and has practiced medicine as an attending physician at Stanford University, the VA Palo Alto Health Care System, and Kaiser Permanente. Dr. Schneider has an undergraduate degree from the College of the Holy Cross, a Doctor of Medicine degree from Johns Hopkins School of Medicine, and a Master of Science degree in Health Services Research from Stanford University. She completed her internal medicine residency at Stanford University Hospital.
Dr. Schneider is a frequent speaker about innovation in healthcare, where she shares her unique perspective as a practicing physician, health services researcher, senior executive and individual who has lived with Type 1 diabetes for more than 30 years. In 2020, Modern Healthcare named Dr. Schneider one of the 50 Most Influential Clinical Executives for her work improving the healthcare experience for people living with chronic conditions. She has three children and is an avid runner and athlete, having completed her first IronMan in 2016.